Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Locafaro G"'
Autor:
Rintala, A., Matcham, F., Radaelli, M., Locafaro, G., Simblett, S., Barattieri di San Pietro, C., Bulgari, V., Burke, P., Devonshire, J., Weyer, J., Wykes, T., Comi, G., Hotopf, M., Myin-Germeys, I.
Publikováno v:
In Journal of Psychosomatic Research September 2019 124
Autor:
Ten Brinke, A, Marek-Trzonkowska, N, Mansilla, MJ, Turksma, AW, Piekarska, K, Iwaszkiewicz-Grzes, D, Passerini, L, Locafaro, G, Punet-Ortiz, J, van Ham, SM, Hernandez-Fuentes, MP, Martinez-Caceres, EM, Gregori, S
Publikováno v:
Frontiers in Immunology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::3cf2aea537a6bd6899b75c168952b024
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=5911
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=5911
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
LOCAFARO, GRAZIA
Le Tr1 sono un subset di cellule regolatorie CD4+ indotte in periferia e caratterizzate dalla produzione di IL-10. Nell’ultimo decennio molte risorse sono state impiegate nella ricerca di metodi efficaci per la produzione di cellule Tr1 in vitro. I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1299::8b69d7572c7d248b3417ad894ee0fd0d
http://hdl.handle.net/10281/83945
http://hdl.handle.net/10281/83945
Autor:
Silvia Gregori, Daniela Tomasoni, Giada Amodio, Grazia Locafaro, Fabio Ciceri, Cristina Tresoldi
Publikováno v:
Journal of Immunology Research
Journal of Immunology Research, Vol 2014 (2014)
Journal of Immunology Research, Vol 2014 (2014)
Human Leukocyte Antigen-G (HLA-G) contributes to cancer cell immune escape from host antitumor responses. The clinical relevance of HLA-G in several malignancies has been reported. However, the role of HLA-G expression and functions in Acute Myeloid
Autor:
Locafaro G, Andolfi G, Russo F, Cesana L, Spinelli A, Camisa B, Ciceri F, Lombardo A, Bondanza A, Roncarolo MG, Gregori S
Publikováno v:
Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2024 Mar 06; Vol. 32 (3), pp. 853-854. Date of Electronic Publication: 2024 Feb 14.
Autor:
Ten Brinke A; Department of Immunopathology, Sanquin Research, Amsterdam, Netherlands.; Landsteiner Laboratory, Academic Medical Centre, University of Amsterdam, Amsterdam, Netherlands., Marek-Trzonkowska N; Laboratory of Immunoregulation and Cellular Therapies, Department of Family Medicine, Medical University of Gdańsk, Gdańsk, Poland., Mansilla MJ; Immunology Division, Department of Cellular Biology, Germans Trias i Pujol University Hospital and Research Institute, Physiology, and Immunology, Universitat Autònoma Barcelona, Barcelona, Spain., Turksma AW; Department of Immunopathology, Sanquin Research, Amsterdam, Netherlands.; Landsteiner Laboratory, Academic Medical Centre, University of Amsterdam, Amsterdam, Netherlands., Piekarska K; Laboratory of Immunoregulation and Cellular Therapies, Department of Family Medicine, Medical University of Gdańsk, Gdańsk, Poland., Iwaszkiewicz-Grześ D; Department of Clinical Immunology and Transplantology, Medical University of Gdańsk, Gdańsk, Poland., Passerini L; San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), Division of Regenerative Medicine, Stem Cells and Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy., Locafaro G; San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), Division of Regenerative Medicine, Stem Cells and Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy., Puñet-Ortiz J; Immunology Division, Department of Cellular Biology, Germans Trias i Pujol University Hospital and Research Institute, Physiology, and Immunology, Universitat Autònoma Barcelona, Barcelona, Spain., van Ham SM; Department of Immunopathology, Sanquin Research, Amsterdam, Netherlands.; Landsteiner Laboratory, Academic Medical Centre, University of Amsterdam, Amsterdam, Netherlands., Hernandez-Fuentes MP; MRC Centre for Transplantation, King's College London, London, United Kingdom., Martínez-Cáceres EM; Immunology Division, Department of Cellular Biology, Germans Trias i Pujol University Hospital and Research Institute, Physiology, and Immunology, Universitat Autònoma Barcelona, Barcelona, Spain., Gregori S; San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), Division of Regenerative Medicine, Stem Cells and Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Publikováno v:
Frontiers in immunology [Front Immunol] 2018 Feb 22; Vol. 9, pp. 343. Date of Electronic Publication: 2018 Feb 22 (Print Publication: 2018).
Autor:
Ten Brinke A; Department of Immunopathology, Sanquin Research, Amsterdam, Netherlands.; Landsteiner Laboratory, Academic Medical Centre, University of Amsterdam, Amsterdam, Netherlands., Marek-Trzonkowska N; Laboratory of Immunoregulation and Cellular Therapies, Department of Family Medicine, Medical University of Gdańsk, Gdańsk, Poland., Mansilla MJ; Immunology Division, Department of Cellular Biology, Germans Trias i Pujol University Hospital and Research Institute, Physiology, and Immunology, Universitat Autònoma Barcelona, Barcelona, Spain., Turksma AW; Department of Immunopathology, Sanquin Research, Amsterdam, Netherlands.; Landsteiner Laboratory, Academic Medical Centre, University of Amsterdam, Amsterdam, Netherlands., Piekarska K; Laboratory of Immunoregulation and Cellular Therapies, Department of Family Medicine, Medical University of Gdańsk, Gdańsk, Poland., Iwaszkiewicz-Grześ D; Department of Clinical Immunology and Transplantology, Medical University of Gdańsk, Gdańsk, Poland., Passerini L; San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), Division of Regenerative Medicine, Stem Cells and Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy., Locafaro G; San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), Division of Regenerative Medicine, Stem Cells and Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy., Puñet-Ortiz J; Immunology Division, Department of Cellular Biology, Germans Trias i Pujol University Hospital and Research Institute, Physiology, and Immunology, Universitat Autònoma Barcelona, Barcelona, Spain., van Ham SM; Department of Immunopathology, Sanquin Research, Amsterdam, Netherlands.; Landsteiner Laboratory, Academic Medical Centre, University of Amsterdam, Amsterdam, Netherlands., Hernandez-Fuentes MP; MRC Centre for Transplantation, King's College London, London, United Kingdom., Martínez-Cáceres EM; Immunology Division, Department of Cellular Biology, Germans Trias i Pujol University Hospital and Research Institute, Physiology, and Immunology, Universitat Autònoma Barcelona, Barcelona, Spain., Gregori S; San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), Division of Regenerative Medicine, Stem Cells and Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Publikováno v:
Frontiers in immunology [Front Immunol] 2017 Dec 21; Vol. 8, pp. 1870. Date of Electronic Publication: 2017 Dec 21 (Print Publication: 2017).
Autor:
Locafaro G; San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, Milan 20132, Italy., Andolfi G; San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, Milan 20132, Italy., Russo F; San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, Milan 20132, Italy., Cesana L; San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, Milan 20132, Italy., Spinelli A; Experimental Imaging Centre, IRCCS San Raffaele Scientific Institute, Milan 20132, Italy., Camisa B; Innovative Immunotherapies Unit, Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan 20132, Italy., Ciceri F; Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan 20132, Italy., Lombardo A; San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, Milan 20132, Italy; Vita Salute San Raffaele University, Milan 20132, Italy., Bondanza A; Experimental Imaging Centre, IRCCS San Raffaele Scientific Institute, Milan 20132, Italy., Roncarolo MG; San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, Milan 20132, Italy; Division of Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, ISCBRM, Stanford School of Medicine, Stanford, CA 94305, USA. Electronic address: mg1@stanford.edu., Gregori S; San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, Milan 20132, Italy. Electronic address: gregori.silvia@hsr.it.
Publikováno v:
Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2017 Oct 04; Vol. 25 (10), pp. 2254-2269. Date of Electronic Publication: 2017 Jul 05.